Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi (MGX) Non-cash Items (2023 - 2025)

Metagenomi (MGX) has disclosed Non-cash Items for 3 consecutive years, with $265000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Non-cash Items fell 62.94% to $265000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $265000.0, a 62.94% decrease, with the full-year FY2025 number at $265000.0, down 62.94% from a year prior.
  • Non-cash Items was $265000.0 for Q4 2025 at Metagenomi, down from $1.1 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $111.0 million in Q4 2023 to a low of $3246.0 in Q2 2024.
  • A 3-year average of $14.3 million and a median of $490000.0 in 2024 define the central range for Non-cash Items.
  • Peak YoY movement for Non-cash Items: crashed 99.36% in 2024, then surged 27335.4% in 2025.
  • Metagenomi's Non-cash Items stood at $111.0 million in 2023, then plummeted by 99.36% to $715000.0 in 2024, then plummeted by 62.94% to $265000.0 in 2025.
  • Per Business Quant, the three most recent readings for MGX's Non-cash Items are $265000.0 (Q4 2025), $1.1 million (Q3 2025), and $890553.0 (Q2 2025).